Filing Details

Accession Number:
0001094891-16-000493
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-23 13:15:56
Reporting Period:
2016-05-20
Filing Date:
2016-05-23
Accepted Time:
2016-05-23 13:15:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1619551 Cb Pharma Acquisition Corp. CNLM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald C/O Cb Pharma Acquisition Corp.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Co-Chairman And Ceo Yes Yes Yes No
1429260 Fortress Biotech, Inc. 3 Columbus Circle, 15Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2016-05-20 1,020,000 $0.00 265,000 No 4 S Indirect By Fortress Biotech, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Fortress Biotech, Inc.
Footnotes
  1. Mr. Rosenwald is the Chairman, President and Chief Executive Officer of Fortress Biotech, Inc. (formerly Coronado Biosciences, Inc.), and as such, controls the voting and disposition of such securities. Mr. Rosenwald disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. Rosenwald is the beneficial owner of these securities for puposes of Section 16 or for any other purpose.
  2. $0.00000095238 per ordinary share.